» Articles » PMID: 27741134

Validity of APCS Score As a Risk Prediction Score for Advanced Colorectal Neoplasia in Chinese Asymptomatic Subjects: A Prospective Colonoscopy Study

Overview
Specialty General Medicine
Date 2016 Oct 15
PMID 27741134
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The Asia-Pacific Colorectal Screening (APCS) score is a risk-stratification tool that helps predict the risk for advanced colorectal neoplasia (ACN) in asymptomatic Asian populations, but has not yet been assessed for its validity of use in Mainland China.The aim of the study was to assess the validity of APCS score in asymptomatic Chinese population, and to identify other risk factors associated with ACN.Asymptomatic subjects (N = 1010) who underwent colonoscopy screening between 2012 and 2014 in Beijing were enrolled. APCS scores based on questionnaires were used to stratify subjects into high, moderate, and average-risk tiers. Cochran-Armitage test for trend was used to assess the association between ACN and risk tiers. Univariate and multivariate logistic regression was performed with ACN as the outcome, adjusting for APCS score, body mass index, alcohol consumption, self-reported diabetes, and use of nonsteroidal anti-inflammatory drugs as independent variables.The average age was 53.5 (standard deviation 8.4) years. The prevalence of ACN was 4.1% overall, and in the high, moderate, and average-risk tiers, the prevalence was 8.8%, 2.83%, and 1.55%, respectively (P < 0.001). High-risk tier had 3.3 and 6.1-fold increased risk of ACN as compared with those in the moderate and average-risk tiers, respectively. In univariate analysis, high-risk tier, obesity, diabetes, and alcohol consumption were associated with ACN. In multivariate analysis, only high-risk tier was an independent predictor of ACN.The APCS score can effectively identify a subset of asymptomatic Chinese population at high risk for ACN. Further studies are required to identify other risk factors, and the acceptability of the score to the general population will need to be further examined.

Citing Articles

Chinese national clinical practice guidelines on prevention, diagnosis and treatment of early colorectal cancer.

Li J, Yao H, Lu Y, Zhang S, Zhang Z Chin Med J (Engl). 2024; 137(17):2017-2039.

PMID: 39104005 PMC: 11374253. DOI: 10.1097/CM9.0000000000003253.


Developing a Nomogram for Predicting Colorectal Cancer and Its Precancerous Lesions Based on Data from Three Non-Invasive Screening Tools, APCS, FIT, and sDNA.

Ze Y, Tu H, Zhao Y, Zhang L J Multidiscip Healthc. 2024; 17:2891-2901.

PMID: 38903878 PMC: 11189322. DOI: 10.2147/JMDH.S465286.


Performance of different colorectal cancer screening strategies: a long-term passive follow-up population-based screening program in Beijing, China.

Zhang X, Yang L, Liu S, Li H, Li Q, Li H BMC Public Health. 2023; 23(1):1640.

PMID: 37641033 PMC: 10463986. DOI: 10.1186/s12889-023-16564-0.


Clinical evaluation of a multitarget fecal immunochemical test-sDNA test for colorectal cancer screening in a high-risk population: a prospective, multicenter clinical study.

Hu Y, Chen X, Zhai C, Yu X, Liu G, Xiong Z MedComm (2020). 2023; 4(4):e345.

PMID: 37576863 PMC: 10422070. DOI: 10.1002/mco2.345.


Opportunistic colonoscopy in healthy individuals: A non-trivial risk of adenoma.

Jin X, Cai C, Zhao J, Huang L, Jin B, Jia Y PLoS One. 2023; 18(4):e0283575.

PMID: 37053293 PMC: 10101387. DOI: 10.1371/journal.pone.0283575.


References
1.
Frezza E, Wachtel M, Chiriva-Internati M . Influence of obesity on the risk of developing colon cancer. Gut. 2005; 55(2):285-91. PMC: 1856517. DOI: 10.1136/gut.2005.073163. View

2.
Imperiale T, Wagner D, Lin C, Larkin G, Rogge J, Ransohoff D . Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002; 346(23):1781-5. DOI: 10.1056/NEJM200206063462304. View

3.
Brown M, Klabunde C, Mysliwiec P . Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med. 2003; 115(2):129-33. DOI: 10.1016/s0002-9343(03)00297-3. View

4.
Flossmann E, Rothwell P . Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007; 369(9573):1603-13. DOI: 10.1016/S0140-6736(07)60747-8. View

5.
Levin T . Colonoscopy capacity: Can we build it? Will they come?. Gastroenterology. 2004; 127(6):1841-4. DOI: 10.1053/j.gastro.2004.10.014. View